SCHEMBL3403370

SCHEMBL3403370

CCOC(=O)c1nc(Br)c2snc(-c3ccccc3)c2c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 2/20 0.45
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 3/20 0.44
MAPK1 P28482 2/20 0.44
ADORA3 P0DMS8 3/20 0.44
CDC7 O00311 2/20 0.43
DBF4 Q9UBU7 2/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
RARA P10276 1/20 0.42
RARB P10826 1/20 0.42
RARG P13631 1/20 0.42
LMNA P02545 2/20 0.42
ATM Q13315 1/20 0.42
TARBP2 Q15633 1/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
NPC1 O15118 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3404689 0.89 TARBP2 (0.46) ALDH1A1HPGDSMN1; SMN2MAPTMAPK1
SCHEMBL3401368 0.89 KDM4E (0.52) ALDH1A1HPGDSMN1; SMN2MAPTMAPK1
SCHEMBL3401768 0.89 ALDH1A1 (0.49) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL3404466 0.86 JAK2 (0.43) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL3407905 0.85 CDC7 (0.53) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL3407275 0.84 ALDH1A1 (0.51) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL3401461 0.84 ALDH1A1 (0.51) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL3405930 0.84 DHODH (0.48) ALDH1A1HPGDHSD17B10MAPTADORA3
SCHEMBL3405938 0.83 DHODH (0.49) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL3780077 0.82 CDC7 (0.48) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9387200-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2016-07-12 US disclosed
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2015-07-30 US disclosed
US-8952160-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2015-02-10 US disclosed
EP-2252619-B1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN INC (US) 2013-10-09 EP disclosed
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2010-12-30 US disclosed
EP-2252619-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY Fibrogen, Inc. (US) 2010-11-24 EP disclosed
WO-2009089547-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 ALDH1A1 256/4885HPGD 52/4885HSD17B10 1231/4885
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 ALDH1A1 284/4885HPGD 55/4885HSD17B10 1402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.